Creating specialized nanoparticles for medical imaging and treatment
Official title: A Fullerene-based Molecular Route towards Designer Nanoparticles
Funded at Rutgers, the State Univ of N.j. · NIH-11088827 · Data updated 2026-11-12
This study is working on creating tiny particles from fullerene molecules that can be used in medicine, especially to help doctors see and treat cancer more effectively.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers, the State Univ of N.j. NIH-funded |
| Lab location | 1 site (Piscataway, United States) |
| Project start | August 1, 2023 |
| Project end | May 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $392,500 |
| NIH project number | 5R35GM151131-03 |
| Project ID | NIH-11088827 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients with cancer who may benefit from improved imaging and targeted therapies.
✕Less likely to help
Patients with conditions unrelated to cancer or those who do not require advanced imaging techniques may not benefit from this research.
What this research studies
This research focuses on developing precise nanoparticles using fullerene molecules, which can be tailored for specific biomedical applications. By utilizing a unique structure of fullerene C60, the researchers aim to create nanoparticles that maintain their size and shape while incorporating biological functions. This approach seeks to improve the effectiveness of diagnostic tools and therapeutic agents, particularly in targeting cancer cells through advanced imaging techniques. The project involves multiple research themes that explore different applications of these molecular nanoparticles in medical imaging.
Why it matters
Potential benefit: If successful, this research could lead to more effective diagnostic and therapeutic tools for cancer treatment.
How similar studies have gone: Other research has shown promise in using nanoparticles for medical applications, indicating that this approach could lead to significant advancements.
Where this research is happening
-
Rutgers, the State Univ of N.j.
Piscataway, United States Active
Researchers
- Principal investigator: Zhang, Jianyuan — Rutgers, the State Univ of N.j.
- Study coordinator: Zhang, Jianyuan
Related research
Other NIH-funded projects on the same topics.
-
Causes and consequences of intra-genomic coevolution
Scientists are studying how repetitive DNA in human cells interacts with proteins to impact genome health, fertility, and cellular functions.
-
How BRAF changes spark serrated colon cancer, from stem cells
This project studies how a BRAF mutation affects colon stem cells to understand what triggers serrated colon cancer.
-
Understanding how copper affects staph bacteria to fight infections
Scientists are studying how copper ions change the proteins inside Staphylococcus aureus to find new ways to treat resistant infections.
-
Sensory guidance of how diet affects healthy aging
Researchers will study how the way we experience food and our senses influence aging, using fruit-fly models to mirror human dietary choices.
-
Non-Invasive AI-Enhanced Neonatal Blood Pressure Monitoring in NICUs
A new AI-powered system uses the baby’s existing sensors to continuously track blood pressure in the NICU without invasive procedures, helping clinicians spot problems early.
-
How the brain drives overeating and weight loss with GLP-1 medications
Scientists are studying how brain circuits that control food seeking respond to obesity and weight loss with a GLP-1 drug, to understand why weight loss often doesn’t hold.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.